Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 23189546)

1.

Multiple organ failure and granulomatous hepatitis following intravesical bacillus Calmette-Guérin instillation.

Desmet M, Moubax K, Haerens M.

Acta Clin Belg. 2012 Sep-Oct;67(5):367-9.

PMID:
23189546
2.

Mediastinal granulomatous lymphadenitis after intravesical bacillus Calmette-Guerin treatment mimicking distant metastasis of primary bladder carcinoma.

Dogan D, Zor M, Ozkisa T, Ayten O, Yigit N, Yavas I.

Arch Bronconeumol. 2015 Mar 20. pii: S0300-2896(15)00066-6. doi: 10.1016/j.arbres.2014.10.015. [Epub ahead of print] English, Spanish. No abstract available.

3.

Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.

Larsen BT, Smith ML, Grys TE, Vikram HR, Colby TV.

Int J Surg Pathol. 2015 May;23(3):189-95. doi: 10.1177/1066896914567332. Epub 2015 Jan 22.

PMID:
25614462
4.

[Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy.]

Raffray L, Rivière P, Bonnet H, Duffau P, Longy-Boursier M.

Rev Med Interne. 2014 Nov 18. pii: S0248-8663(14)01016-9. doi: 10.1016/j.revmed.2014.10.361. [Epub ahead of print] French.

PMID:
25467298
5.

Fatal sepsis after intravesical instillation of BCG: case report.

Andrade E Silva UV, Viana LD, Oliveira E Castro PD, Almeida RD, Silva RS.

Rev Bras Ter Intensiva. 2011 Mar;23(1):104-107. English, Portuguese.

PMID:
25299561
6.

Penile tuberculosis after intravesical bacille Calmette-Guérin immunotherapy.

Linden-Castro E, Pelayo-Nieto M, Alias-Melgar A.

Urology. 2014 Aug;84(2):e3. doi: 10.1016/j.urology.2014.04.037. Epub 2014 Jun 21.

PMID:
24958483
7.

Resolution without treatment of granulomatous pneumonitis due to intravesical BCG for bladder cancer.

Venn RM, Sharma N.

BMJ Case Rep. 2014 May 2;2014. pii: bcr2014204440. doi: 10.1136/bcr-2014-204440.

PMID:
24792029
8.

Bacillus Calmette-Guérin (osis).

Thupili CR, Chamarthi SK, Ghosh S.

J Urol. 2014 Jun;191(6):1876-7. doi: 10.1016/j.juro.2014.02.2564. Epub 2014 Mar 1. No abstract available.

PMID:
24593879
9.

Granulomatous hepatitis as a rare complication of Bacillus Calmette-Guérin vaccination.

Shoaran M, Najafi M, Jalilian R, Rezaei N.

Ann Saudi Med. 2013 Nov-Dec;33(6):627-9. doi: 10.5144/0256-4947.2013.627.

PMID:
24413871
10.

Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy.

Delimpoura V, Samitas K, Vamvakaris I, Zervas E, Gaga M.

BMJ Case Rep. 2013 Oct 10;2013. pii: bcr2013200624. doi: 10.1136/bcr-2013-200624.

PMID:
24114600
11.

Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.

Mizoguchi H, Iida O, Dohi T, Tomoda K, Kimura H, Inoue K, Iwata T, Tei K, Miura T.

Ann Vasc Surg. 2013 Nov;27(8):1186.e1-5. doi: 10.1016/j.avsg.2012.12.004. Epub 2013 Aug 21.

PMID:
23972639
12.

Perianal abscess as a complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer.

Köksal AS, Bilge Z, Torun S, Saşmaz N, Yazicioğlu AH.

Acta Gastroenterol Belg. 2013 Jun;76(2):260. No abstract available.

PMID:
23898568
13.

Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.

Miyazaki J, Hinotsu S, Ishizuka N, Naito S, Ozono S, Akaza H, Nishiyama H.

Jpn J Clin Oncol. 2013 Aug;43(8):827-34. doi: 10.1093/jjco/hyt086. Epub 2013 Jul 14.

14.

Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.

Sternberg IA, Dalbagni G, Chen LY, Donat SM, Bochner BH, Herr HW.

J Urol. 2013 Nov;190(5):1686-91. doi: 10.1016/j.juro.2013.04.120. Epub 2013 May 7.

PMID:
23665400
15.

Fever of unknown origin and pancytopenia caused by culture-proven delayed onset disseminated bacillus Calmette-Guerin (BCG) infection after intravesical instillation.

Dammert P, Boujaoude Z, Rafferty W, Kass J.

BMJ Case Rep. 2013 Apr 9;2013. pii: bcr2013008949. doi: 10.1136/bcr-2013-008949.

16.

Intravesical bacillus Calmette-Guérin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation.

Swietek N, Waldert M, Susani M, Schatzl G, Klatte T.

Wien Klin Wochenschr. 2013 Apr;125(7-8):189-95. doi: 10.1007/s00508-013-0343-1. Epub 2013 Mar 28. Review.

PMID:
23536017
17.

Maintenance therapy with intravesical bacillus Calmette-Guerin in patients with intermediate- or high-risk non-muscle-invasive bladder cancer.

Muto S, Nakajima A, Horiuchi A, Inoue M, China T, Saito K, Isotani S, Hisasue S, Yamaguchi R, Ide H, Horie S.

Jpn J Clin Oncol. 2013 Mar;43(3):305-13. doi: 10.1093/jjco/hys225. Epub 2013 Jan 9.

18.

[Granulomatous hepatitis and sepsis secondary to intravesical instillation of bacillus Calmette-Guérin].

Garmilla-Ezquerra P, Martínez-De Las Cuevas G, Hernández-Hernández JL.

Enferm Infecc Microbiol Clin. 2012 Dec;30(10):656-7. doi: 10.1016/j.eimc.2012.04.010. Epub 2012 Jun 9. Spanish. No abstract available.

PMID:
22683174
19.

[A case with hepatitis and interstitial pneumonitis caused by intravesical bacillus Calmette-Guérin (BCG) instillation].

Uetsuki H, Hirama H, Matsuoka Y, Miyauchi Y, Tsunemori H, Yamashita M, Inui M, Sugimoto M, Kakehi Y.

Nihon Hinyokika Gakkai Zasshi. 2011 Sep;102(5):691-5. Review. Japanese.

PMID:
22191278
20.

Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria.

Herr HW.

J Urol. 2012 Feb;187(2):435-7. doi: 10.1016/j.juro.2011.10.032. Epub 2011 Dec 15.

PMID:
22177154
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk